Results 131 to 140 of about 2,048,259 (212)

Refractory anemia with ring sideroblasts in a young individual [PDF]

The Korean Journal of Hematology, 2010
Cho, Jin-Hee, Hur, Mina, Kim, Sung Yong
openaire   +2 more sources

Ring Sideroblast Measurement [PDF]

, 2020
openaire   +1 more source

Modelling ineffective erythropoiesis in myelodysplastic syndromes with ring sideroblasts

, 2019
Myelodysplastic syndromes with ring sideroblast (MDS-RS) is a clonal hematological malignancy characterized by accumulation of iron filled erythroblasts called ring sideroblasts in the bone marrow, and recurrent somatic mutations in the splicing factor ...
Edda María Elvarsdóttir (19494340)
core  

Modelling ineffective erythropoiesis in myelodysplastic syndromes with ring sideroblasts [Elektronisk resurs]

, 2019
Myelodysplastic syndromes with ring sideroblast (MDS-RS) is a clonal hematological malignancy characterized by accumulation of iron filled erythroblasts called ring sideroblasts in the bone marrow, and recurrent somatic mutations in the splicing factor ...
Elvarsdóttir, EM,
core  

Luspatercept in myelodysplastic syndrome with ring sideroblasts: a case report of intrapulmonary vascular dilatation syndrome causing protracted inexplicable hypoxia. [PDF]

Haematologica
Warsi A, Faughnan ME, Buckstein R.
europepmc   +1 more source

Monolobated megakaryocytes and ring sideroblasts: A morphological prelude to multihit TP53 and complex karyotype. [PDF]

Br J Haematol
Marco-Ayala J, Chen T, Ortuño FJ, Lozano ML.   +3 more
europepmc   +1 more source

MDS/MPN With SF3B1 Mutation and Thrombocytosis but Without Ring Sideroblasts. [PDF]

Am J Hematol
Hazarika B, Bain BJ.
europepmc   +1 more source

Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutations. [PDF]

J Hematop
Hebeda KM, Boudová L, Corsten MF, Ptáková N, Haferlach T, de Graaf AO, Cermak J, Vanecek T, Jansen JH, Stevens-Kroef MJPL, Kroeze LI.   +10 more
europepmc   +1 more source

Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM. [PDF]

Br J Haematol
D'Aveni M, Schenone L, Torregrosa JM, Pardo J, Stamatoullas A, Saillard C, Thépot S, Dimicoli S, Santana C, Daguindau E, Paul F, Le Clech L, Park S, Cluzeau T, Paubelle E, Taksin-Bressot AL, Chermat F, Adès L, Fenaux P, Comont T.   +19 more
europepmc   +1 more source